Multiple Award IDIQ Construction Contract
Closed Special Notice Posted
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 236220 Commercial and Institutional Building Construction
- Place of performance
- Maryland 21702, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, National Cancer Institute is conducting a sources sought for a multiple award IDIQ subcontract for construction services at Frederick National Laboratory for Cancer Research, with capability statements due September 18, 2026 at 4:00 p.m. The subcontract will be issued by Leidos Biomedical Research, Inc. (Leidos Biomed) and performed under Leidos Biomed's existing prime contract 75N91019D00024. Work is classified under PSC Code Y (construction of structures and facilities) and NAICS 236220 (commercial and institutional building construction). Prospective offerors must submit capability statements to demonstrate qualifications for construction work at the Frederick facility. The sources sought document is available at https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr or by email request to Matthew Hull, Contracts Manager at matthew.hull@nih.gov or 301-846-6998. The notice will be automatically archived 600 days after the response deadline.
Notice text
National Institutes of Health, National Cancer Institute, Frederick National Laboratory for Cancer Research Opportunities-Special Announcements: Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires an Indefinite Delivery/Indefinite Quantity Subcontract for construction services for the Frederick National Laboratory for Cancer Research (FNLCR).
To obtain a copy of the Sources Sought please click the following link:
https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr
or email Leidos Biomedical Research POC: Contracts Manager, Matthew Hull @ matthew.hull@nih.gov
Background Information: Leidos Biomedical Research, Inc. (Leidos Biomed), a subsidiary of Leidos Corporation, a Delaware corporation with offices in Frederick, MD is the Operations and Technical Support (OTS) contractor for the National Cancer Institute at Frederick. The effort to be performed will be part of Leidos Biomed’s Prime Contract 75N91019D00024 that has been issued by the National Cancer Institute, National Institutes of Health, Frederick, MD.
Leidos Biomedical Research, Inc. POC: Contracts Manager at matthew.hull@nih.gov
For information concerning other opportunities with the FNLCR, please refer to:
https://frederick.cancer.gov/work-us/vendors-subcontractors/business-opportunities/multiple-award-idiq-construction-contract-fnlcr or contact the Leidos Biomedical Research Point of Contact listed in this announcement.
Files
| File | Type | Posted |
|---|---|---|
| SAM Request (Sources Sought) revised_8.13.2026.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Construction Contract Sources Sought | National Nuclear Security Administration | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity